Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that AstraZeneca (NYSE: AZN) has added a second development candidate, ISIS-ARRx, to its collaboration ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE